Syndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. IBM
7. NKE
8. MU
9. USO
10. NVDA

Go back to Syndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals (SNDX) Tops Q2 EPS by 13c

August 7, 2018 4:24 PM EDT

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q2 EPS of ($0.74), $0.13 better than the analyst estimate of ($0.87).

"We made great progress across multiple programs during the first half of this year, including presentation of data from all three cohorts of ENCORE 601 and completion of target enrollment in ENCORE 602 and 603. We... More